Galectin Therapeutics Inc. ( GALT) - Stock Earnings
GALT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -8.2 million USD | — USD |
| 2025Q4 | -5.5 million USD | — USD |
| 2026Q1 | -5.0 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GALT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -41.1 million USD | — USD |
| 2024 | -47.0 million USD | — USD |
| 2025 | -30.8 million USD | — USD |
| 2026 Est. | — | — |
GALT
Price: $2.35
52 week price:
Earnings Per Share: -0.41 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 205300
Ebitda: -4.4 millionMarket Capitalization: 177.8 million